Company type
Limited Corporation (APS)
Established
2020
Size
Micro
Employees
-
Revenue
- DKK
Gross profit
-19,894 DKK
Operating Profit (EBIT)
-19,894 DKK
Profit for the year
-19,894 DKK
Equity
20,106 DKK
ad

More financial key figures and analyses?

In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!

Rank Profit for the year

Rank in industry
17/35
"Around avg"
Rank in Denmark
266,677/334,976
"Lowest 35%"

Top management - top 3

Legal owners - top 3

100%aiwell Inc.

Rights certificate

 Selskabet tegnes af direktørerne i forening.

Company information based on CVR

NameAiwell Nordic Aps
CVR41699094
AddressOle Maaløes Vej 3, 2200 København N
IndustryManufacture of basic pharmaceutical products [211000]
Established23-09-2020 (2 yr)
Company typeLimited Corporation (APS)
Number of employees-
Advertising protectionNo
AuditorGrant Thornton,Statsautoriseret Revisionspartnerselskab since 23-09-2020
Financial statement period01-01 to 31-12
Company capital40,000 DKK
Articles of assoc. last23-09-2020

Member of industries

Purpose

Selskabets formål er at foreta-ge analytiske test af biologiske prøver. R&D, teknisk træning, forskning på bestilling, import, eksport, fremstilling, konditio-nering og salg af diagnostice-rings-/ testkits, farmaceutiske produkter, kvasi-lægemidler, dyremediciner, antistoffer, en-heder. R&D, drift og vedlige-holdelse af lifescience / biolo-giske datamanagement sy-stemer. Fremstilling, leasing og salg af paramedicinske og medicinsk e apparaturer. R&D inden for avanceret medicinsk teknologi. Samt hermed be-slægtet virksomhed.

Financial Statement

 2020
Currency/unit000' DKK
Revenue
-
-
Gross Profit
-20
-
Profit for the year
-20
-
Equity
20
-
Total Assets
40
-

Mangement review

Development in activities and financial matters
The gross loss for the year totals tDKK -20. Income or loss from the year totals tDKK -20.

Management considers the net loss for the year unsatisfactory
25-06-2021

Map